Visioneering Technologies (ASX:VTI) ROCE % : -73.24% (As of Jun. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Visioneering Technologies ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Visioneering Technologies's annualized ROCE % for the quarter that ended in Jun. 2024 was -73.24%.

Visioneering Technologies ROCE % Historical Data

The historical data trend for Visioneering Technologies's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Visioneering Technologies ROCE % Chart

Visioneering Technologies Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-195.93

-265.54

-26.84

-56.12

-49.67

Visioneering Technologies Semi-Annual Data
	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
ROCE %	Get a 7-Day Free Trial										-53.16	-59.36	-56.00	-60.88	-73.24

Visioneering Technologies ROCE % Calculation

Visioneering Technologies's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-5.026	/	( ( (13.497 - 2.061)	+	(11.423 - 2.623) )	/ 2 )
	=	-5.026	/	( (11.436	+	8.8)	/ 2 )
	=	-5.026	/	10.118
	=	-49.67 %

Visioneering Technologies's ROCE % of for the quarter that ended in Jun. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2024 )		(Q: Dec. 2023 )		(Q: Jun. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2024 )		(Q: Dec. 2023 )		(Q: Jun. 2024 )
	=	-5.668	/	( ( (11.423 - 2.623)	+	(9.211 - 2.533) )	/ 2 )
	=	-5.668	/	( ( 8.8	+	6.678 )	/ 2 )
	=	-5.668	/	7.739
	=	-73.24 %

(1) Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

Visioneering Technologies (ASX:VTI) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Visioneering Technologies ROCE % Related Terms

Thank you for viewing the detailed overview of Visioneering Technologies's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Visioneering Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Visioneering Technologies Inc (ASX:VTI) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

30 Mansell Court, Suite 215, Alpharetta, GA, USA, 30076

Website

http://www.vtivision.com

Visioneering Technologies Inc is a medical device company. It designs, manufactures, sells, and distributes its NaturalVue daily disposable multifocal contact lenses for adults with Presbyopia and children with Myopia. The company offers NaturalVue MF contact lenses. Its Multifocal contact lens provides Presbyopia patients with near, intermediate, and distance vision, making it much easier for eye care professionals to fit their patients. It has two reportable segments; North America which includes its operations in the United States and Canada; and Europe/Asia Pacific which includes its operations outside North America.